Results
Oxygenta Pharmaceutical Q2 Loss Narrows to ₹3.4 Crore
Oxygenta Pharmaceutical reported Q2 FY27 revenue of ₹33.49 crore, up 134% YoY from ₹14.30 crore in Q2 FY26.
Quarterly net loss narrowed to ₹2.74 crore from ₹4.93 crore YoY, with half-year loss at ₹4.8
